Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial
Authors:
- Nicolas VerheyenNVNicolas Verheyen
- Andreas MeinitzerAMAndreas Meinitzer
- Martin Robert GrüblerMGMartin Robert Grübler
- Klemens AblasserKAKlemens Ablasser
- Ewald KolesnikEKEwald Kolesnik
- Astrid Fahrleitner-PammerAFAstrid Fahrleitner-Pammer
- Evgeny BelyavskiyEBEvgeny Belyavskiy
- Christian TrummerCTChristian Trummer
- Verena SchwetzVSVerena Schwetz
- Elisabeth Pieske-KraigherEPElisabeth Pieske-Kraigher
- Jakob VoelklJVJakob Voelkl
- Ioana AlesutanIAIoana Alesutan
- 1 January 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 55 (7) , 1034-1042
Abstract
Background: Primary hyperparathyroidism (pHPT) is associated with low-grade inflammation, left ventricular hypertrophy and increased cardiovascular mortality, but the association between inflammatory markers and parameters of adverse cardiac remodeling is unknown. We investigated the relationship between C-reactive protein (CRP), the essential amino acid tryptophan and its pro-inflammatory derivatives kynurenine and quinolinic acid (QUIN) with echocardiographic parameters.Methods: Cross-sectional baseline data from the “Eplerenone in Primary Hyperparathyroidism” trial were analyzed. Patients with any acute illness were excluded. We assessed associations between CRP, serum levels of tryptophan, kynurenine and QUIN and left ventricular mass index (LVMI), left atrial volume index (LAVI) and E/e′.Results: Among 136 subjects with pHPT (79% females), 100 (73%) had arterial hypertension and the prevalence of left ventricular hypertrophy was 52%. Multivariate linear regression analyses with LVMI, LAVI and E/e′ as respective dependent variables, and C-reactive protein and tryptophan, kynurenine and QUIN as respective independent variables were performed. Analyses were adjusted for age, sex, blood pressure, parathyroid hormone, calcium and other cardiovascular risk factors. LVMI was independently associated with CRP (adjusted β-coefficient=0.193, p=0.030) and QUIN (β=0.270, p=0.007), but not kynurenine. LAVI was related with CRP (β=0.315, p<0.001), kynurenine (β=0.256, p=0.005) and QUIN (β=0.213, p=0.044). E/e′ was related with kynurenine (β=0.221, p=0.022) and QUIN (β=0.292, p=0.006). Tryptophan was not associated with any of the remodeling parameters.[Correction added after online publication (22 April 2017: The sentence “Among 136 subjects with pHPT (79% females), 100 (73%) had left ventricular hypertrophy.” was corrected to “Among 136 subjects with pHPT (79% females), 100 (73%) had arterial hypertension and the prevalence of left ventricular hypertrophy was 52%.”]Conclusions: Cardiac remodeling is common in pHPT and is associated with low-grade inflammation and activation of the tryptophan-kynurenine pathway. The potential role of kynurenine and QUIN as cardiovascular risk factors may be further investigated in future studies.Keywords
This publication has 36 references indexed in Scilit:
- HIV-1 gp120 induces autophagy in cardiomyocytes via the NMDA receptorInternational Journal of Cardiology, 2013
- Quinolinic Acid: An Endogenous Neurotoxin with Multiple TargetsOxidative Medicine and Cellular Longevity, 2013
- Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trialBMC Endocrine Disorders, 2012
- Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contractionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- White Blood Cell Count, C-Reactive Protein, and Incident Heart Failure in the Atherosclerosis Risk in Communities (ARIC) StudyAnnals of Epidemiology, 2011
- Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidismScandinavian Journal of Clinical and Laboratory Investigation, 2010
- Quinolinate phosphoribosyl transferase, a key enzyme in de novo NAD+ synthesis, suppresses spontaneous cell death by inhibiting overproduction of active-caspase-3Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: Protective role of apocyninJournal of Neuroscience Research, 2009
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathwayThe International Journal of Biochemistry & Cell Biology, 2009